Arezoo Asadi
Overview
Explore the profile of Arezoo Asadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darbandi A, Koupaei M, Kiani P, Ghanavati R, Najafi P, Hosseini J, et al.
Immun Inflamm Dis
. 2024 Nov;
12(11):e70076.
PMID: 39570098
Background: Despite the advent of vaccines against COVID-19, there is considerable variation in the acceptance and hesitancy towards the vaccination program across different countries. The objective of this study was...
2.
Heidary M, Sholeh M, Koupaei M, Asadi A, Khah S, Kheirabadi F, et al.
Diagn Microbiol Infect Dis
. 2024 Nov;
108(1):116088.
PMID: 39491944
Tigecycline (TG) is one of the newest antimicrobial drugs used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. The TG Resistance Evaluation and Monitoring Test (T.E.S.T.) is a global...
3.
Mahdizade Ari M, Shahroodian S, Afifirad R, Asadollahi P, Asadi A, Darbandi T, et al.
Curr Pharm Biotechnol
. 2024 May;
PMID: 38818910
Introduction: This systematic review aimed to summarize the currently available evidence on the effect of oral probiotic therapy on infected wound healing among patients who underwent surgery. Materials And Methods:...
4.
Heidary M, Dashtbin S, Asadi A, Asadollahi P, Khatib A, Ebrahimi M, et al.
Future Microbiol
. 2024 Mar;
19:449-459.
PMID: 38497912
This study aimed to understand the current level of linezolid (LNZ) resistance in isolates reported over the past 10 years. An electronic search was conducted for the following keywords: ((...
5.
Koupaei M, Asadi A, Mahdizade Ari M, Seyyedi Z, Mohammadi F, Afifi Rad R, et al.
Diagn Microbiol Infect Dis
. 2023 Dec;
108(2):116105.
PMID: 38147789
This study aims to investigate the development of secondary bacterial infection and risk factors associated with it in critical COVID-19 patients, and to identify the most common pathogen groups in...
6.
Anvari H, Binabaj M, Asadi A, Abdi M, Shakiba A, Heidary M, et al.
Clin Lab
. 2023 Nov;
69(11).
PMID: 37948496
Introduction: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of hepatitis, an important disease affecting millions of people worldwide. The present study aimed to estimate...
7.
Shirani M, Pakzad R, Haddadi M, Akrami S, Asadi A, Kazemian H, et al.
BMC Infect Dis
. 2023 Aug;
23(1):543.
PMID: 37598157
Background: Helicobacter pylori is a gastrointestinal pathogen that infects around half of the world's population. H. pylori infection is the most severe known risk factor for gastric cancer (GC), which...
8.
Kouhsari E, Kaviar V, Asadi A, Ahmadi A, Sholeh M, Mirbalouchzehi A, et al.
Infect Disord Drug Targets
. 2023 May;
23(7):17-28.
PMID: 37170999
Bacterial Persister Cells (BPCs) are quiescent, slow-growing or growth-arrested phenotypic variants of normal bacterial cells that are transiently tolerant to antibiotics. It seems that persister cells are the main cause...
9.
Mehdizadeh Sari F, Mirkalantari S, Nikoo S, Sepahvand F, Allahqoli L, Asadi A, et al.
Iran J Microbiol
. 2022 Dec;
14(5):698-704.
PMID: 36531824
Background And Objectives: Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity. Peripheral blood monocytes cells (PBMCs) may have altered function to some extent in women...
10.
Azimi T, Khoshnood S, Asadi A, Heidary M, Mahmoudi H, Kaviar V, et al.
Front Pharmacol
. 2022 Sep;
13:955050.
PMID: 36110536
Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant tuberculosis (MDR-TB) treatment failure. strains resistant to isoniazid and rifampin are defined as MDR-TB. In recent years, resistance to...